<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-04-11" modified="2020-08-12" version="162">
<accession>Q9HAW7</accession>
<accession>B8K293</accession>
<accession>O00473</accession>
<name>UD17_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="17">UDP-glucuronosyltransferase 1A7</fullName>
<shortName>UGT1A7</shortName>
<ecNumber evidence="4 7 8 9 10 12 13">2.4.1.17</ecNumber>
</recommendedName>
<alternativeName>
<fullName>UDP-glucuronosyltransferase 1-7</fullName>
<shortName>UDPGT 1-7</shortName>
<shortName>UGT1*7</shortName>
<shortName>UGT1-07</shortName>
<shortName>UGT1.7</shortName>
</alternativeName>
<alternativeName>
<fullName>UDP-glucuronosyltransferase 1-G</fullName>
<shortName>UGT-1G</shortName>
<shortName>UGT1G</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="29">UGT1A7</name>
<name type="synonym">GNT1</name>
<name type="synonym">UGT1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Mol. Pharmacol." volume="52" first="212" last="220">
<title>Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.</title>
<authorList>
<person name="Strassburg C.P."/>
<person name="Oldhafer K."/>
<person name="Manns M.P."/>
<person name="Tukey R.H."/>
</authorList>
<dbReference type="PubMed" id="9271343"/>
<dbReference type="DOI" id="10.1124/mol.52.2.212"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="Pharmacogenetics" volume="11" first="357" last="368">
<title>Thirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.</title>
<authorList>
<person name="Gong Q.H."/>
<person name="Cho J.W."/>
<person name="Huang T."/>
<person name="Potter C."/>
<person name="Gholami N."/>
<person name="Basu N.K."/>
<person name="Kubota S."/>
<person name="Carvalho S."/>
<person name="Pennington M.W."/>
<person name="Owens I.S."/>
<person name="Popescu N.C."/>
</authorList>
<dbReference type="PubMed" id="11434514"/>
<dbReference type="DOI" id="10.1097/00008571-200106000-00011"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LYS-129; LYS-131 AND ARG-208</scope>
</reference>
<reference key="3">
<citation type="submission" date="2006-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Guillemette C."/>
<person name="Levesque E."/>
<person name="Girard H."/>
<person name="Bernard O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANTS LYS-129 AND LYS-131</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Mol. Pharmacol." volume="62" first="608" last="617">
<title>Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).</title>
<authorList>
<person name="Gagne J.F."/>
<person name="Montminy V."/>
<person name="Belanger P."/>
<person name="Journault K."/>
<person name="Gaucher G."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="12181437"/>
<dbReference type="DOI" id="10.1124/mol.62.3.608"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Drug Metab. Dispos." volume="33" first="139" last="146">
<title>Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.</title>
<authorList>
<person name="Picard N."/>
<person name="Ratanasavanh D."/>
<person name="Premaud A."/>
<person name="Le Meur Y."/>
<person name="Marquet P."/>
</authorList>
<dbReference type="PubMed" id="15470161"/>
<dbReference type="DOI" id="10.1124/dmd.104.001651"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="4821" last="4829">
<title>Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.</title>
<authorList>
<person name="Operana T.N."/>
<person name="Tukey R.H."/>
</authorList>
<dbReference type="PubMed" id="17179145"/>
<dbReference type="DOI" id="10.1074/jbc.m609417200"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Mol. Pharm." volume="4" first="883" last="894">
<title>Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.</title>
<authorList>
<person name="Joseph T.B."/>
<person name="Wang S.W."/>
<person name="Liu X."/>
<person name="Kulkarni K.H."/>
<person name="Wang J."/>
<person name="Xu H."/>
<person name="Hu M."/>
</authorList>
<dbReference type="PubMed" id="18052087"/>
<dbReference type="DOI" id="10.1021/mp700135a"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Pharmacogenet. Genomics" volume="17" first="1077" last="1089">
<title>Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity.</title>
<authorList>
<person name="Girard H."/>
<person name="Levesque E."/>
<person name="Bellemare J."/>
<person name="Journault K."/>
<person name="Caillier B."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="18004212"/>
<dbReference type="DOI" id="10.1097/fpc.0b013e3282f1f118"/>
</citation>
<scope>FUNCTION (ISOFORMS 1 AND 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="76" first="763" last="772">
<title>The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.</title>
<authorList>
<person name="Alonen A."/>
<person name="Finel M."/>
<person name="Kostiainen R."/>
</authorList>
<dbReference type="PubMed" id="18674515"/>
<dbReference type="DOI" id="10.1016/j.bcp.2008.07.006"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Drug Metab. Dispos." volume="36" first="2307" last="2315">
<title>The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.</title>
<authorList>
<person name="Itaeaho K."/>
<person name="Mackenzie P.I."/>
<person name="Ikushiro S."/>
<person name="Miners J.O."/>
<person name="Finel M."/>
</authorList>
<dbReference type="PubMed" id="18719240"/>
<dbReference type="DOI" id="10.1124/dmd.108.022731"/>
</citation>
<scope>FUNCTION (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Drug Metab. Dispos." volume="38" first="1785" last="1789">
<title>Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.</title>
<authorList>
<person name="Bellemare J."/>
<person name="Rouleau M."/>
<person name="Girard H."/>
<person name="Harvey M."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="20610558"/>
<dbReference type="DOI" id="10.1124/dmd.110.034835"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="Drug Metab. Dispos." volume="41" first="694" last="697">
<title>The relative protein abundance of UGT1A alternative splice variants as a key determinant of glucuronidation activity in vitro.</title>
<authorList>
<person name="Rouleau M."/>
<person name="Roberge J."/>
<person name="Falardeau S.A."/>
<person name="Villeneuve L."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="23360619"/>
<dbReference type="DOI" id="10.1124/dmd.112.050468"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Pharmacogenetics" volume="10" first="629" last="644">
<title>Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene.</title>
<authorList>
<person name="Guillemette C."/>
<person name="Ritter J.K."/>
<person name="Auyeung D.J."/>
<person name="Kessler F.K."/>
<person name="Housman D.E."/>
</authorList>
<dbReference type="PubMed" id="11037804"/>
<dbReference type="DOI" id="10.1097/00008571-200010000-00006"/>
</citation>
<scope>VARIANTS LYS-129; LYS-131 AND ARG-208</scope>
<scope>CHARACTERIZATION OF ALLELES</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="677" last="687">
<title>Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.</title>
<authorList>
<person name="Menard V."/>
<person name="Girard H."/>
<person name="Harvey M."/>
<person name="Perusse L."/>
<person name="Guillemette C."/>
</authorList>
<dbReference type="PubMed" id="19204906"/>
<dbReference type="DOI" id="10.1002/humu.20946"/>
</citation>
<scope>VARIANTS LYS-129; LYS-131 AND ARG-208</scope>
</reference>
<comment type="function">
<molecule>Isoform 1</molecule>
<text evidence="4 5 7 8 9 10 12 13">UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:15470161, PubMed:18052087, PubMed:18004212, PubMed:18674515, PubMed:18719240, PubMed:20610558, PubMed:23360619). Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds (PubMed:12181437, PubMed:18004212). Catalyzes the glucuronidation of endogenous estrogen hormone epiestradiol (PubMed:18719240). Also catalyzes the glucuronidation of the isoflavones genistein, daidzein, glycitein, formononetin, biochanin A and prunetin, which are phytoestrogens with anticancer and cardiovascular properties (PubMed:18052087). Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist caderastan, a drug which can inhibit the effect of angiotensin II (PubMed:18674515). Involved in the biotransformation of 7-ethyl-10-hydroxycamptothecin (SN-38), the pharmacologically active metabolite of the anticancer drug irinotecan (PubMed:12181437, PubMed:18004212, PubMed:20610558, PubMed:23360619). Also metabolizes mycophenolate, an immunosuppressive agent (PubMed:15470161).</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="7 12 13">Lacks UGT glucuronidation activity but acts as a negative regulator of isoform 1.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="4 5 7 8 9 10 12 13">
<text>glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor beta-D-glucuronoside + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:21032"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:132367"/>
<dbReference type="ChEBI" id="CHEBI:132368"/>
<dbReference type="EC" id="2.4.1.17"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="20 21 24 25 26 27 28">
<dbReference type="Rhea" id="RHEA:21033"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="10">
<text>17alpha-estradiol + UDP-alpha-D-glucuronate = 17alpha-estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP</text>
<dbReference type="Rhea" id="RHEA:52868"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17160"/>
<dbReference type="ChEBI" id="CHEBI:57529"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="26">
<dbReference type="Rhea" id="RHEA:52869"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="5">
<text>mycophenolate + UDP-alpha-D-glucuronate = H(+) + mycophenolate 7-O-beta-D-glucuronide + UDP</text>
<dbReference type="Rhea" id="RHEA:63704"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:62932"/>
<dbReference type="ChEBI" id="CHEBI:149486"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="21">
<dbReference type="Rhea" id="RHEA:63705"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="4 7 12">
<text>SN-38 + UDP-alpha-D-glucuronate = H(+) + SN-38 O-beta-D-glucuronide + UDP</text>
<dbReference type="Rhea" id="RHEA:63696"/>
<dbReference type="ChEBI" id="CHEBI:8988"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:149482"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="20 23 27">
<dbReference type="Rhea" id="RHEA:63697"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="8">
<text>prunetin + UDP-alpha-D-glucuronate = prunetin-5-O-beta-D-glucuronide + UDP</text>
<dbReference type="Rhea" id="RHEA:63612"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:147403"/>
<dbReference type="ChEBI" id="CHEBI:147405"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="24">
<dbReference type="Rhea" id="RHEA:63613"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="9">
<text>candesartan + UDP-alpha-D-glucuronate = candesartan O-beta-D-glucuronoside + UDP</text>
<dbReference type="Rhea" id="RHEA:63724"/>
<dbReference type="ChEBI" id="CHEBI:58052"/>
<dbReference type="ChEBI" id="CHEBI:58223"/>
<dbReference type="ChEBI" id="CHEBI:149509"/>
<dbReference type="ChEBI" id="CHEBI:149522"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="25">
<dbReference type="Rhea" id="RHEA:63725"/>
</physiologicalReaction>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="10">37.1 uM for 17alpha-estradiol/epiestradiol (when assaying glucuronidation at position 3)</KM>
<KM evidence="5">480 uM for mycophenolate (when assaying glucuronidation at position 7)</KM>
<KM evidence="4">1.2 uM for SN-38 (when assaying glucuronidation at position 10)</KM>
<KM evidence="12">9.8 uM for SN-38 (when assaying glucuronidation at position 10)</KM>
<Vmax evidence="10">94.2 pmol/min/mg enzyme for the formation of 17alpha-estradiol 3-O-(beta-D-glucuronate)</Vmax>
<Vmax evidence="5">7140 pmol/min/mg enzyme for the formation of mycophenolate 7-O-glucuronide</Vmax>
<Vmax evidence="4">8 pmol/min/mg enzyme for the formation of SN-38 glucuronide</Vmax>
<Vmax evidence="12">5 pmol/min/mg enzyme for the formation of SN-38 glucuronide</Vmax>
<Vmax evidence="8">140 pmol/min/mg enzyme for the formation of prunetin-5-O-(beta-D-glucuronoside)</Vmax>
<text evidence="24">Some kinetic parameters were assessed using commercial enzymes, which may represent a mix of both active and inactive protein forms, and therefore modify the kinetic values.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="6 12 27">Homodimer (PubMed:17179145). Homooligomer (Probable). Interacts with UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A8, UGT1A9 and UGT1A10 to form heterodimers (PubMed:17179145). Isoform 1 interacts with isoform 2/i2 suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2. Isoform 1 also interacts with respective i2 isoforms of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A8, UGT1A9 and UGT1A10 (PubMed:20610558).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22">Endoplasmic reticulum membrane</location>
<topology evidence="1">Single-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9HAW7-1</id>
<name>1</name>
<name evidence="16">i1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9HAW7-2</id>
<name>2</name>
<name evidence="16">i2</name>
<name>UGT1A7s</name>
<sequence type="described" ref="VSP_053963"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7 14">Liver and gastric tissue (PubMed:9271343). Isoform 1 and isoform 2 are expressed in esophagus. Neither isoform is expressed in liver, kidney, colon and small intestine (PubMed:18004212).</text>
</comment>
<comment type="polymorphism">
<text evidence="2">There are four common allelic UGT1A7 variants which exhibit significant differences in catalytic activity towards 3-, 7-, and 9-hydroxy-benzo(a)pyrene. UGT1A7*3 exhibits a 5.8-fold lower relative Vmax compared to UGT1A7*1, whereas UGT1A7*2 and UGT1A7*4 have a 2.6- and 2.8-fold lower relative Vmax than UGT1A7*1, respectively, suggesting that these mutations confer slow glucuronidation phenotype.</text>
</comment>
<comment type="miscellaneous">
<text evidence="7">UGT1A7 isoform is part of the UGT1A complex locus which displays alternative use of promoters, first exons and terminal exons. The locus is defined by 13 first exons, which are alternatively spliced to 3 other common exons and 2 alternative terminal exons 5. From the 27 possible mRNA isoforms, 9 produce functionally active polypeptides (UGT1A1, 1A3, 1A4, 1A5, 1A6, 1A7, 1A8, 1A9 and 1A10) called isoforms 1 (i1). Use of an alternative exon 5 (5b) as terminal exon is leading to 9 additional alternatively spliced products termed isoforms i2 and which lack transferase activity.</text>
</comment>
<comment type="similarity">
<text evidence="19">Belongs to the UDP-glycosyltransferase family.</text>
</comment>
<dbReference type="EC" id="2.4.1.17" evidence="4 7 8 9 10 12 13"/>
<dbReference type="EMBL" id="U89507">
<property type="protein sequence ID" value="AAB81536.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF297093">
<property type="protein sequence ID" value="AAG30419.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ383513">
<property type="protein sequence ID" value="ABD42926.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006985">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC114812">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2506.1">
<molecule id="Q9HAW7-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_061950.2">
<molecule id="Q9HAW7-1"/>
<property type="nucleotide sequence ID" value="NM_019077.2"/>
</dbReference>
<dbReference type="SMR" id="Q9HAW7"/>
<dbReference type="BioGRID" id="120055">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="IntAct" id="Q9HAW7">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000362525"/>
<dbReference type="BindingDB" id="Q9HAW7"/>
<dbReference type="ChEMBL" id="CHEMBL1743317"/>
<dbReference type="DrugBank" id="DB00564">
<property type="generic name" value="Carbamazepine"/>
</dbReference>
<dbReference type="DrugBank" id="DB14635">
<property type="generic name" value="Curcumin sulfate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00783">
<property type="generic name" value="Estradiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00555">
<property type="generic name" value="Lamotrigine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00688">
<property type="generic name" value="Mycophenolate mofetil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01024">
<property type="generic name" value="Mycophenolic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00788">
<property type="generic name" value="Naproxen"/>
</dbReference>
<dbReference type="DrugBank" id="DB09079">
<property type="generic name" value="Nintedanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00794">
<property type="generic name" value="Primidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00503">
<property type="generic name" value="Ritonavir"/>
</dbReference>
<dbReference type="DrugBank" id="DB00197">
<property type="generic name" value="Troglitazone"/>
</dbReference>
<dbReference type="DrugCentral" id="Q9HAW7"/>
<dbReference type="CAZy" id="GT1">
<property type="family name" value="Glycosyltransferase Family 1"/>
</dbReference>
<dbReference type="GlyConnect" id="1879">
<property type="glycosylation" value="2 N-Linked glycans (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q9HAW7">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9HAW7"/>
<dbReference type="PhosphoSitePlus" id="Q9HAW7"/>
<dbReference type="BioMuta" id="UGT1A7"/>
<dbReference type="DMDM" id="30173486"/>
<dbReference type="jPOST" id="Q9HAW7"/>
<dbReference type="MassIVE" id="Q9HAW7"/>
<dbReference type="MaxQB" id="Q9HAW7"/>
<dbReference type="PaxDb" id="Q9HAW7"/>
<dbReference type="PeptideAtlas" id="Q9HAW7"/>
<dbReference type="PRIDE" id="Q9HAW7"/>
<dbReference type="ProteomicsDB" id="81454">
<molecule id="Q9HAW7-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="35223">
<property type="antibodies" value="32 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="54577"/>
<dbReference type="Ensembl" id="ENST00000373426">
<molecule id="Q9HAW7-1"/>
<property type="protein sequence ID" value="ENSP00000362525"/>
<property type="gene ID" value="ENSG00000244122"/>
</dbReference>
<dbReference type="GeneID" id="54577"/>
<dbReference type="KEGG" id="hsa:54577"/>
<dbReference type="UCSC" id="uc002vut.4">
<molecule id="Q9HAW7-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="54577"/>
<dbReference type="DisGeNET" id="54577"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000244122.2"/>
<dbReference type="GeneCards" id="UGT1A7"/>
<dbReference type="HGNC" id="HGNC:12539">
<property type="gene designation" value="UGT1A7"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000244122">
<property type="expression patterns" value="Group enriched (esophagus, lymphoid tissue, tongue)"/>
</dbReference>
<dbReference type="MIM" id="191740">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="606432">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9HAW7"/>
<dbReference type="OpenTargets" id="ENSG00000244122"/>
<dbReference type="PharmGKB" id="PA37182"/>
<dbReference type="eggNOG" id="KOG1192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000163976"/>
<dbReference type="HOGENOM" id="CLU_012949_3_1_1"/>
<dbReference type="InParanoid" id="Q9HAW7"/>
<dbReference type="KO" id="K00699"/>
<dbReference type="OMA" id="PMVMIPL"/>
<dbReference type="PhylomeDB" id="Q9HAW7"/>
<dbReference type="TreeFam" id="TF315472"/>
<dbReference type="BRENDA" id="2.4.1.17">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q9HAW7"/>
<dbReference type="Reactome" id="R-HSA-156588">
<property type="pathway name" value="Glucuronidation"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9HAW7"/>
<dbReference type="BioGRID-ORCS" id="54577">
<property type="hits" value="17 hits in 772 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="UGT1A7_(gene)"/>
<dbReference type="GenomeRNAi" id="54577"/>
<dbReference type="Pharos" id="Q9HAW7">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9HAW7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="Q9HAW7">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000244122">
<property type="expression patterns" value="Expressed in esophagus and 53 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9HAW7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9HAW7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008144">
<property type="term" value="F:drug binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004857">
<property type="term" value="F:enzyme inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015020">
<property type="term" value="F:glucuronosyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001972">
<property type="term" value="F:retinoic acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052695">
<property type="term" value="P:cellular glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009804">
<property type="term" value="P:coumarin metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017144">
<property type="term" value="P:drug metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007588">
<property type="term" value="P:excretion"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006631">
<property type="term" value="P:fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051552">
<property type="term" value="P:flavone metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052696">
<property type="term" value="P:flavonoid glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001030">
<property type="term" value="P:negative regulation of cellular glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045922">
<property type="term" value="P:negative regulation of fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904224">
<property type="term" value="P:negative regulation of glucuronosyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042573">
<property type="term" value="P:retinoic acid metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052697">
<property type="term" value="P:xenobiotic glucuronidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR002213">
<property type="entry name" value="UDP_glucos_trans"/>
</dbReference>
<dbReference type="InterPro" id="IPR035595">
<property type="entry name" value="UDP_glycos_trans_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00201">
<property type="entry name" value="UDPGT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00375">
<property type="entry name" value="UDPGT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0328">Glycosyltransferase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="UDP-glucuronosyltransferase 1A7" id="PRO_0000036006">
<location>
<begin position="26"/>
<end position="530"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="488"/>
<end position="504"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="71"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="292"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="344"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_053963" evidence="18">
<original>SYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH</original>
<variation>RKKQQSGRQM</variation>
<location>
<begin position="432"/>
<end position="530"/>
</location>
</feature>
<feature type="sequence variant" description="In allele UGT1A7*2 and allele UGT1A7*3; dbSNP:rs17868323." id="VAR_015556" evidence="2 3 11 15">
<original>N</original>
<variation>K</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In allele UGT1A7*2 and allele UGT1A7*3; dbSNP:rs386656364." id="VAR_015557" evidence="2 3 11 15">
<original>R</original>
<variation>K</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17868324." id="VAR_052462">
<original>R</original>
<variation>Q</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In allele UGT1A7*3 and allele UGT1A7*4; dbSNP:rs11692021." id="VAR_015558" evidence="2 3 11">
<original>W</original>
<variation>R</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB81536." ref="1" evidence="19">
<original>V</original>
<variation>A</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB81536." ref="1" evidence="19">
<original>Y</original>
<variation>F</variation>
<location>
<position position="433"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11037804"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11434514"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12181437"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15470161"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17179145"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18004212"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18052087"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18674515"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18719240"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19204906"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20610558"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23360619"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9271343"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18004212"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18719240"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<evidence key="20" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12181437"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15470161"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17179145"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18004212"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18052087"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18674515"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18719240"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20610558"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23360619"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:12539"/>
</source>
</evidence>
<sequence length="530" mass="59819" checksum="7D759A382AE871D3" modified="2003-04-23" version="2" precursor="true">MARAGWTGLLPLYVCLLLTCGFAKAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMPEVSWQLGRSLNCTVKTYSTSYTLEDQDREFMVFADARWTAPLRSAFSLLTSSSNGIFDLFFSNCRSLFNDRKLVEYLKESCFDAVFLDPFDACGLIVAKYFSLPSVVFARGIFCHYLEEGAQCPAPLSYVPRLLLGFSDAMTFKERVWNHIMHLEEHLFCPYFFKNVLEIASEILQTPVTAYDLYSHTSIWLLRTDFVLEYPKPVMPNMIFIGGINCHQGKPVPMEFEAYINASGEHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

